Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kristiansen, M. A. M. Articles by Rasmussen, T. B. Search for Related Content PubMed PubMed Citation Articles by Kristiansen, M. A. M. Articles by Rasmussen, T. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2003, p. 4462-4464, Vol. 41, No. 9
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.9.4462-4464.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

In Vivo Development of Quinolone Resistance in Salmonella enterica Serotype Typhimurium DT104

Malthe A. Melau Kristiansen,^1* Dorthe Sandvang,² and Thorkild Bremholm Rasmussen³

Department of Clinical Microbiology, Research Unit for Clinical Microbiology, University of Southern Denmark, 6400 Sønderborg,¹ Statens Serum Institut, 2300 Copenhagen,² Department of Surgery A, Odense University Hospital, 5000 Odense, Denmark³

Received 24 March 2003/ Returned for modification 1 May 2003/ Accepted 2 June 2003

Top Abstract Text References

 
Salmonella enterica serotype Typhimurium definitive phage type 104 was isolated several times from the same patient over a period of 2 years. The strain developed reduced sensitivity to fluoroquinolones, and a mutation in the gyrA gene that is associated with reduced sensitivity to quinolones was identified.

Top Abstract Text References

 
Salmonella enterica serotype Typhimurium definitive phage type 104 (DT104) has been reported with increasing frequency worldwide throughout the last decade in both humans and farm animals. The majority of Danish Salmonella serotype Typhimurium DT104 isolates are pentaresistant, and the genes encoding the resistance marker have been characterized and sequenced (2, 11). The five resistance genes are located on the chromosome in a large gene cluster that was sequenced by Briggs and Fratamico in 1999 (2) and have been shown to be mobile (14). In contrast to that finding, the resistance mechanism for the quinolones is single-point mutations in the gyrase genes resulting in decreased affinity of DNA gyrase for the quinolone (3, 6).

This study describes the course of illness of a 51-year-old woman over a period of 2 years. Prior to the study, she had undergone sigmoid resection due to perisigmoiditis complicated by a ureter lesion and leakage of the sigmoid anastomosis, both of which had been corrected surgically, and a colostomy had just recently been corrected. An abdominal ultrasound had shown cholecystolithiasis. She was admitted to the medical ward on 15 May 1999 due to diarrhea and dehydration. Within 24 h, the patient's temperature spiked to 40°C and her blood pressure dropped to 65 mm Hg, necessitating her transfer to the intensive care unit, where she received IVs containing metronidazole (500 mg every 8 h [q8h]), ceftriaxon (2g twice a day), and dopamine (10 µg/kg of body weight/min). On 26 May, blood cultures yielded Salmonella serotype Typhimurium DT104 organisms that were fully susceptible to fluoroquinolones. The antibiotic treatment was changed to oral ciprofloxacin (250 mg q12h), which was continued until 4 June, after which the patient was deemed to be free of the Salmonella serotype Typhimurium DT104 infection and was discharged from the hospital.

The patient was readmitted 9 August 2000 due to hypotension, fever, and pain in her left buttocks. An abscess in the gluteal region due to a fistula emanating from the sigmoid anastomosis was identified. The gluteal fascia was split, pus was cultured, and the patient was administered IVs of ampicillin (1g q6h) and metronidazole (500 mg q12h) until 1 September and gentamicin from 9 August to 12 August. Gentamicin was replaced by intravenous ciprofloxacin (200 mg q12h) on 12 August, and ciprofloxacin therapy was continued until 1 September due to culture yielding Streptococcus, ampicillin-resistant Escherichia coli, and Bacteroides. The patient gradually recovered and was deemed free of Salmonella serotype Typhimurium DT104. The patient was readmitted 11 December 2000 due to retraction of the colostomy. Her colon was rejoined, and an ileostomy was performed. Shortly after surgery, she fell ill and produced thin green stool in her stoma. A stool specimen was cultivated, and there was growth of Salmonella serotype Typhimurium DT104 once again. The patient was left untreated and recovered spontaneously. Feces specimens were cultivated again in mid-January 2001 and 5 September 2001, and both yielded Salmonella serotype Typhimurium DT104. In the interim, an attempt had been made to eradicate the Salmonella with a 4-week course of oral ciprofloxacin (250 mg q12h).

Colonies of Salmonella subsp. were serially isolated and serotyped as Salmonella enterica serotype Typhimurium DT104 (Table 1), described by Callow (4) and Anderson et al. (1). A susceptibility test was conducted in accordance with the method and materials described by Threlfall et al. (15), and the MIC of ciprofloxacin was determined by the E-test (AB Biodisk, Solna, Sweden). The extraction and preparation of DNA were performed as described by Gautom (5), and XbaI and BlnI were used for digestion (Roche Holding Ltd., Basel, Switzerland). Isolation of plasmid DNA from bacterial strains and subsequent profiling were performed as described by Kado and Liu (7). DNA preparation and PCR were performed according to the methods of Sandvang et al. (13) and Sandvang (12). The gyrA gene (GenBank accession no. X06744) (16) was amplified by using the primers gyrA-F (base pairs 186 to 213) and gyrA-B (base pairs 811 to 784) and resulted in a PCR product of 626 bp. The PCR products were purified and sequenced according to the methods of Sandvang (12).

View this table: [in this window] [in a new window]

TABLE 1. Comparison of Salmonella serovar Typhimurium DT104 strains

The pulsed-field gel electrophoresis (PFGE) pattern of the DNA digests yielded approximately 15 bands in the area between 50 and 1,000 kb (Fig. 1). Visual comparison showed that the PFGE patterns of the four Salmonella strains were indistinguishable. Plasmid profiling revealed that the four strains all had two small plasmids of approximate 2.2- and 2.6-kb lengths as well as the large 95-kb serotype-associated plasmid (virulence plasmid). All the Salmonella serotype Typhimurium DT104 strains contained the 626-bp gyrase PCR amplicons (16). The three nalidixic acid-resistant Salmonella serotype Typhimurium DT104 strains showed one-point mutations in the gyrA gene. A point mutation from C to T at nt 431 in the gyrA gene (16) was found. The location of this substitution corresponds to the codon 83 (numbered according to Yoshida et al.) (16). A point mutation from TCC to TTC (with the change marked in bold) resulted in an amino acid substitution from serine to phenylalanine. This substitution is well known to result in decreased susceptibility to quinolones (9, 10).

View larger version (92K): [in this window] [in a new window]

FIG. 1. PFGE illustrating the DNA pattern from the four Salmonella enterica serotype Typhimurium DT104 strains from the same patient, digested with restriction enzyme BlnI (left) or XbaI (right).

In the above case, the patient developed Salmonella serotype Typhimurium DT104 septicemia secondary to a gastrointestinal infection. The Salmonella serotype Typhimurium DT104 primarily found in the patient's blood before antibiotic treatment showed full susceptibility to fluoroquinolones. The patient was treated with low doses of ciprofloxacin (250 mg q12h) for 9 days, and three succeeding cultivations of feces over the next year still yielded Salmonella serotype Typhimurium DT104 organisms. Although the indistinguishable PFGE patterns indicate complete identity among all four serial isolates, the second isolate of this series had reduced susceptibility to ciprofloxacin, (MIC, 0.190 µg/ml) compared with that of the first ciprofloxacin-susceptible isolate (MIC, 0.008 µg/ml). Resistance to ciprofloxacin remained for the next isolates and correlated with a mutation present in the gyrA gene. Although epidemiological studies suggest a relationship between the use of quinolones and the development of quinolone resistance, to our knowledge this is the first time that the evolution of ciprofloxacin resistance in Salmonella serotype Typhimurium DT104 has been directly linked to quinolone therapy in a patient.

 
Jette Kristiansen is gratefully acknowledged for her comments. We thank Lene Bay for providing technical assistance and Leonard Amaral for helpful discussion.

 
* Corresponding author. Mailing address: Department of Clinical Microbiology, Research Unit for Clinical Microbiology, University of Southern Denmark, Sønderborg Sygehus, Sydvang 1, 6400 Sønderborg, Denmark. Phone: 45 22 17 60 86. Fax: 45 74 18 27 43. E-mail: makblast{at}hotmail.com.

Top Abstract Text References

 

1
1. Anderson, E. S., L. R. Ward, M. J. de Saxe, and J. D. H. de Sa. 1977. Bacteriophage-typing designations of Salmonella Typhimurium. J. Hyg. Camb. 78:297-300.[Medline]
2
2. Briggs, C. E., and P. M. Fratamico. 1999. Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104. Antimicrob. Agents Chemother. 43:846-849.[Abstract/Free Full Text]
3
3. Brown, J. C., C. J. Thomson, and S. G. Amyes. 1996. Mutations of the gyrA gene of clinical isolates of Salmonella Typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs. J. Antimicrob. Chemother. 37:351-356.[Abstract/Free Full Text]
4
4. Callow, B. R. 1959. A new phage-typing scheme for Salmonella Typhimurium. J. Hyg. Camb. 57:346-359.
5
5. Gautom, R. K. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J. Clin. Microbiol. 35:2977-2980.[Abstract/Free Full Text]
6
6. Heisig, P. 1993. High-level fluoroquinolone resistance in a Salmonella Typhimurium isolate due to alterations in both gyrA and gyrB genes. J. Antimicrob. Chemother. 32:367-377.[Abstract/Free Full Text]
7
7. Kado, C. I., and S. T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.[Abstract/Free Full Text]
8
8. McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. Wilson. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.[CrossRef][Medline]
9
9. Ouabdesselam, S., J. Tankovic, and C. J. Soussy. 1996. Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella. Microb. Drug Resist. 2:299-302.[Medline]
10
10. Reyna, F., M. Huesca, V. Gonzalez, and L. Y. Fuchs. 1995. Salmonella Typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 39:1621-1623.[Abstract/Free Full Text]
11
11. Ridley, A., and E. J. Threlfall. 1998. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104. Microb. Drug Resist. 4:113-118.[Medline]
12
12. Sandvang, D. 1999. Novel streptomycin and spectinomycin resistance gene as a gene cassette within a class 1 integron isolated from Escherichia coli. Antimicrob. Agents Chemother. 43:3036-3038.[Abstract/Free Full Text]
13
13. Sandvang, D., F. M. Aarestrup, and L. B. Jensen. 1997. Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica Typhimurium DT104. FEMS Microbiol. Lett. 157:177-181.[CrossRef][Medline]
14
14. Sandvang, D., M. Diggle, and D. J. Platt. 2002. Translocation of integron-associated resistance in a natural system: acquisition of resistance determinants by Inc P and Inc W plasmids from Salmonella enterica Typhimurium DT104. Microb. Drug. Resist. 8:151-160.[CrossRef][Medline]
15
15. Threlfall, E. J., I. S. Fisher, L. R. Ward, H. Tschape, and P. Gerner-Smidt. 1999. Harmonization of antibiotic susceptibility testing for Salmonella: results of a study by 18 national reference laboratories within the European Union-funded Enter-net group. Microb. Drug Resist. 5:195-200.[Medline]
16
16. Yoshida, H., T. Kojima, J. Yamagishi, and S. Nakamura. 1988. Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol. Gen. Genet. 211:1-7.[CrossRef][Medline]

---

Journal of Clinical Microbiology, September 2003, p. 4462-4464, Vol. 41, No. 9
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.9.4462-4464.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Bagger-Skjot, L., Nielsen, E. M., Sandvang, D., Ethelberg, S., Monnet, D. L., Hammerum, A. M. (2007). Less frequent Salmonella serovars as a reservoir of antimicrobial resistance. J Antimicrob Chemother 59: 814-815 [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kristiansen, M. A. M. Articles by Rasmussen, T. B. Search for Related Content PubMed PubMed Citation Articles by Kristiansen, M. A. M. Articles by Rasmussen, T. B.